Novo Nordisk AS has slashed prices of its blockbuster weight-loss drugs Ozempic and Wegovy in India, amid an onslaught of copycat drugs in the world's third most overweight population. Many patients ...

March 31 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and 48% in India, to fend off ...

Following its FDA approval in the summer, Tonix Pharma's fibromyalgia therapy Tonmya has been launched onto the market in the US, becoming the first new drug for the painful condition in more than 16 ...

Mumbai: Last week, the central government announced that it is collaborating with states to promote the use of generic medicines in government hospitals. As per regulations set by the National Medical ...

March 31 (Reuters) - Novo Nordisk on Tuesday cut the prices of its diabetes and weight-loss drugs ‌Ozempic and Wegovy by as much as 36% ‌and 48% in India, its second such move, to fend off competition ...

Gilead Sciences' already dominant position in HIV pre-exposure prophylaxis (PrEP) could be extended if the FDA approves a new twice-yearly product later this year. The US regulator has started a ...

TORONTO — Anne Welch worked a physically demanding job at her local SPCA — lifting pets, cleaning kennels and walking dogs — until she retired at age 71. With the loss of that physical activity, ...

Indian pharmaceutical stocks traded under pressure on Wednesday after US President Donald Trump said he would sharply raise tariffs on imported medicines. In an interview with CNBC, he said he would ...

A fresh note from Jefferies puts Sun Pharmaceutical Industries at the centre of attention as the United States prepares possible tariffs on medicines, with the brokerage saying exposure exists but the ...